Xencor, Inc.
Fc VARIANTS WITH ALTERED BINDING TO FcRn
Last updated:
Abstract:
The present application relates to optimized IgG immunoglobulin variants, engineering methods for their generation, and their application, particularly for therapeutic purposes.
Status:
Application
Type:
Utility
Filling date:
13 Dec 2021
Issue date:
14 Apr 2022